Compare RLX Technology Inc (RLX) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
RLX Technology Inc vs Health Care Select Sector SPDR Fund — how do they compare? RLX Technology Inc trades at $1.73 (market cap $2.10B), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 20.7× RLX Technology Inc's market cap, and RLX Technology Inc pays a 5.81% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold RLX Technology Inc for 35 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| RLX | XLV | |
|---|---|---|
Market Cap | $2.10B | $43.48B |
Volume | 1,079,706 | 11,121,431 |
Sector | Consumer Staples | — |
52-Week High | $2.57 | $175.68 |
52-Week Low | $1.68 | $141.95 |
Typical Hold Time | 35 Days | 100 Days |
Enterprise Value | $832.26M | — |
Dividend Yield | 5.81% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RLX trades at $1.72, near its 52-week low, with a bearish technical signal and mixed earnings history, missing EPS estimates in recent quarters. The company reported $3.62B revenue and $921.87M net income for 2025, with profitability margins showing strength but international expansion driving growth amid margin compression. Recent news highlights share price weakness and strategic acquisitions in Europe.
The outlook remains cautious due to near-term earnings misses and bearish technicals, but discounted valuation and international growth offer potential upside. Key risks include regulatory pressures and competitive threats in the e-vapor market, while analyst sentiment is neutral with a single hold rating.
XLV trades at $168.16, down 0.39% on the day, with technical indicators showing a bearish bias as the ETF tests key support levels. The healthcare ETF maintains a competitive 0.08% expense ratio and offers diversified exposure to 60 S&P 500 healthcare stocks. Recent options activity shows increased put volume, suggesting some investor caution despite the sector's defensive characteristics.
The healthcare sector's defensive nature and potential Fed rate hike resilience provide stability, though technical weakness and political volatility around midterm elections present near-term risks. XLV's low-cost structure and broad diversification make it an efficient vehicle for healthcare exposure, but sector-specific headwinds like drug trial failures warrant monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About RLX Technology Inc
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
